Literature DB >> 19896333

Cortical neuritic plaques and hippocampal neurofibrillary tangles are related to dementia severity in elderly schizophrenia patients.

Michael A Rapp1, Michal Schnaider-Beeri, Dushyant P Purohit, Abraham Reichenberg, Susan R McGurk, Vahram Haroutunian, Philip D Harvey.   

Abstract

Cognitive decline has been described in elderly patients with schizophrenia, but the underlying pathology remains unknown. Some studies report increases in plaques and neurofibrillary tangles, but there is no evidence for an increased risk for Alzheimer's disease (AD) in elderly schizophrenics. Models of a decreased cerebral reserve suggest that increases in AD-related neuropathology below the threshold for a neuropathological diagnosis could be related to dementia severity in elderly schizophrenia patients. We tested this hypothesis in 110 autopsy specimens of schizophrenia patients, without a neuropathological diagnosis of AD or other neurodegenerative disorders. Furthermore, we assessed the effects of apolipoprotein E (ApoE) status, a known genetic risk factor for AD. Measures of density of neuritic plaques were obtained in five cortical regions, and the degree of hippocampal neurofibrillary tangles was rated. Dementia severity was measured prior to postmortem using the Clinical Dementia Rating (CDR) scale. multivariate analyses of variance were conducted with the factors dementia severity, by ApoE4 carrier status. Hippocampal neurofibrillary tangles correlated with increased dementia severity (p<.05). Neuritic plaque density increased with greater dementia severity (p<.005), and ApoE4 carrier status (p<.005), and these differences were magnified by the ApoE4 carrier status (p<.01). Even below the threshold for a neuropathological diagnosis of AD, neuritic plaques and hippocampal neurofibrillary tangles are associated with dementia severity in schizophrenia patients, even more so in the presence of genetic risk factors, suggesting that a decreased cerebral reserve in elderly schizophrenics may increase susceptibility for dementia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19896333      PMCID: PMC2795077          DOI: 10.1016/j.schres.2009.10.013

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  37 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Amyloid beta pathology in Alzheimer's disease and schizophrenia.

Authors:  Dorota Religa; Hanna Laudon; Maria Styczynska; Bengt Winblad; Jan Näslund; Vahram Haroutunian
Journal:  Am J Psychiatry       Date:  2003-05       Impact factor: 18.112

3.  Frequency of Alzheimer's disease in a postmortem study of psychiatric patients.

Authors:  L Buhl; M Bojsen-Møller
Journal:  Dan Med Bull       Date:  1988-06

4.  The positive and negative syndrome scale (PANSS) for schizophrenia.

Authors:  S R Kay; A Fiszbein; L A Opler
Journal:  Schizophr Bull       Date:  1987       Impact factor: 9.306

5.  A population-based cohort study of premorbid intellectual, language, and behavioral functioning in patients with schizophrenia, schizoaffective disorder, and nonpsychotic bipolar disorder.

Authors:  Abraham Reichenberg; Mark Weiser; Jonathan Rabinowitz; Asaf Caspi; James Schmeidler; Mordechai Mark; Zeev Kaplan; Michael Davidson
Journal:  Am J Psychiatry       Date:  2002-12       Impact factor: 18.112

6.  Six-year follow-up study of cognitive and functional status across the lifespan in schizophrenia: a comparison with Alzheimer's disease and normal aging.

Authors:  J I Friedman; P D Harvey; T Coleman; P J Moriarty; C Bowie; M Parrella; L White; D Adler; K L Davis
Journal:  Am J Psychiatry       Date:  2001-09       Impact factor: 18.112

7.  Head circumference and incident Alzheimer's disease: modification by apolipoprotein E.

Authors:  A Borenstein Graves; J A Mortimer; J D Bowen; W C McCormick; S M McCurry; G D Schellenberg; E B Larson
Journal:  Neurology       Date:  2001-10-23       Impact factor: 9.910

8.  Cognitive impairment in schizophrenia.

Authors:  M A Taylor; R Abrams
Journal:  Am J Psychiatry       Date:  1984-02       Impact factor: 18.112

9.  Age disorientation in chronic schizophrenia is not associated with pre-morbid intellectual impairment or past physical treatment.

Authors:  N Buhrich; T J Crow; E C Johnstone; D G Owens
Journal:  Br J Psychiatry       Date:  1988-04       Impact factor: 9.319

10.  Institutionalization and the defects of schizophrenia.

Authors:  E C Johnstone; D G Owens; A Gold; T J Crow; J F MacMillan
Journal:  Br J Psychiatry       Date:  1981-09       Impact factor: 9.319

View more
  12 in total

1.  The Course and Correlates of Everyday Functioning in Schizophrenia.

Authors:  Abraham Reichenberg; Concetta Feo; Davide Prestia; Christopher R Bowie; Thomas L Patterson; Philip D Harvey
Journal:  Schizophr Res Cogn       Date:  2014-03-01

2.  Apolipoprotein E-ε4 allele predicts escalation of psychotic symptoms in late adulthood.

Authors:  Katherine Jonas; Sean Clouston; Kaiqiao Li; Laura J Fochtmann; Todd Lencz; Anil K Malhotra; David Cicero; Greg Perlman; Evelyn J Bromet; Roman Kotov
Journal:  Schizophr Res       Date:  2018-12-21       Impact factor: 4.939

3.  Saitohin polymorphism and executive dysfunction in schizophrenia.

Authors:  Marta Bosia; Mariachiara Buonocore; Carmelo Guglielmino; Adele Pirovano; Cristina Lorenzi; Alessandra Marcone; Placido Bramanti; Stefano F Cappa; Eugenio Aguglia; Enrico Smeraldi; Roberto Cavallaro
Journal:  Neurol Sci       Date:  2011-12-21       Impact factor: 3.307

4.  Proxy measures of premortem cognitive aptitude in postmortem subjects with schizophrenia.

Authors:  Jill R Glausier; Mary Ann Kelly; Samantha Salem; Kehui Chen; David A Lewis
Journal:  Psychol Med       Date:  2019-03-14       Impact factor: 7.723

Review 5.  Β-Amyloid Burden is Not Associated with Cognitive Impairment in Schizophrenia: A Systematic Review.

Authors:  Jun Ku Chung; Shinichiro Nakajima; Eric Plitman; Yusuke Iwata; Danielle Uy; Philip Gerretsen; Fernando Caravaggio; M Mallar Chakravarty; Ariel Graff-Guerrero
Journal:  Am J Geriatr Psychiatry       Date:  2016-04-29       Impact factor: 4.105

6.  The NSW brain tissue resource centre: Banking for alcohol and major neuropsychiatric disorders research.

Authors:  G T Sutherland; D Sheedy; J Stevens; T McCrossin; C C Smith; M van Roijen; J J Kril
Journal:  Alcohol       Date:  2016-03-14       Impact factor: 2.405

7.  Hippocampal abnormalities and age in chronic schizophrenia: morphometric study across the adult lifespan.

Authors:  N Pujol; R Penadés; C Junqué; I Dinov; C H Y Fu; R Catalán; N Ibarretxe-Bilbao; N Bargalló; M Bernardo; A Toga; R J Howard; S G Costafreda
Journal:  Br J Psychiatry       Date:  2014-09-11       Impact factor: 9.319

8.  Increased Risk of Dementia Among Veterans With Bipolar Disorder or Schizophrenia Receiving Care in the VA Health System.

Authors:  Eileen P Ahearn; Benjamin R Szymanski; Peijun Chen; Martha Sajatovic; Ira R Katz; John F McCarthy
Journal:  Psychiatr Serv       Date:  2020-06-10       Impact factor: 3.084

9.  Psychiatric Aspects of Dementia.

Authors:  Chiadi U Onyike
Journal:  Continuum (Minneap Minn)       Date:  2016-04

10.  The relationship between dopamine receptor D1 and cognitive performance.

Authors:  Jonathan Tsang; John F Fullard; Stella G Giakoumaki; Pavel Katsel; Pavel Katsel; Vasiliki Eirini Karagiorga; Tiffany A Greenwood; David L Braff; Larry J Siever; Panos Bitsios; Vahram Haroutunian; Panos Roussos
Journal:  NPJ Schizophr       Date:  2015-03-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.